Unknown

Dataset Information

Effects of combinations of gapmer antisense oligonucleotides on the target reduction.


ABSTRACT:

Background

The co-administration of several therapeutic oligonucleotides targeting the same transcript is a beneficial approach. It broadens the target sites for diseases associated with various mutations or splice variants. However, little is known how a combination of antisense oligonucleotides (ASOs), which is one of the major modalities of therapeutic oligonucleotides, affects the potency. In this study, we aimed to elucidate the combination-effects of ASOs and the relationship between the target sites and potency of different combinations.

Method and results

We designed 113 ASOs targeting human superoxide dismutase 1 pre-mRNA and found 13 ASOs that had comparable silencing activity in vitro. An analysis of combination-effects on the silencing potency of 37 pairs of two

SUBMITTER: Yanagidaira M 

PROVIDER: S-EPMC9925919 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature